Reciprocal Regulation between SIRT6 and miR-122 Controls Liver Metabolism and Predicts Hepatocarcinoma Prognosis

Cell Rep. 2016 Jan 12;14(2):234-42. doi: 10.1016/j.celrep.2015.12.023. Epub 2015 Dec 31.

Abstract

Mice overexpressing the longevity protein SIRT6 or deficient for the liver's most prevalent microRNA miR-122 display a similar set of phenotypes, including improved lipid profile and protection against damage linked to obesity. Here, we show that miR-122 and SIRT6 negatively regulate each other's expression. SIRT6 downregulates miR-122 by deacetylating H3K56 in the promoter region. MiR-122 binds to three sites on the SIRT6 3' UTR and reduces its levels. The interplay between SIRT6 and miR-122 is manifested in two physiologically relevant ways in the liver. First, they oppositely regulate a similar set of metabolic genes and fatty acid β-oxidation. Second, in hepatocellular carcinoma patients, loss of a negative correlation between SIRT6 and miR-122 expression is significantly associated with better prognosis. These findings show that SIRT6 and miR-122 negatively regulate each other to control various aspects of liver physiology and SIRT6-miR-122 correlation may serve as a biomarker for hepatocarcinoma prognosis.

Keywords: SIRT6; fatty acid oxidation; miR-122.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Fatty Acids / metabolism
  • Humans
  • Liver / pathology*
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Mice
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • Oxidation-Reduction
  • Prognosis
  • Sirtuins / genetics*
  • Sirtuins / metabolism*

Substances

  • Fatty Acids
  • MIRN122 microRNA, human
  • MicroRNAs
  • SIRT6 protein, human
  • Sirtuins